OncoSil Medical Limited (ASX:OSL)

OncoSil Medical Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	5.11	4.5	9.39	11.28	12.24
Cash & Short-Term Investments	5.11	4.5	9.39	11.28	12.24
Cash Growth	13.51%	-52.08%	-16.72%	-7.84%	-41.71%
Accounts Receivable	1.21	1.36	1.16	0.85	1.11
Other Receivables	-0	0.07	0.12	0.06	0.08
Receivables	1.2	1.44	1.29	0.91	1.18
Prepaid Expenses	0.41	0.39	0.44	0.47	0.11
Other Current Assets	-	-	0.12	0.09	0.09
Total Current Assets	6.72	6.33	11.23	12.74	13.62
Property, Plant & Equipment	0.42	0.39	0.24	0.32	0.53
Total Assets	7.15	6.72	11.47	13.07	14.15
Accounts Payable	1.92	1.12	0.96	0.93	1.23
Accrued Expenses	0.43	0.34	0.16	0.34	0.51
Current Portion of Leases	0.05	0.03	0.15	0.17	0.16
Other Current Liabilities	1.63	0.45	0.3	0.33	0.23
Total Current Liabilities	4.03	1.94	1.57	1.77	2.13
Long-Term Leases	0.02	0.04	0.02	0.14	0.32
Total Liabilities	4.04	1.98	1.59	1.91	2.45
Common Stock	96.43	90.09	86.51	79.91	70.4
Retained Earnings	-107.46	-92.78	-84.37	-73.02	-62.3
Comprehensive Income & Other	14.14	7.42	7.74	4.28	3.6
Shareholders' Equity	3.1	4.74	9.88	11.16	11.7
Total Liabilities & Equity	7.15	6.72	11.47	13.07	14.15
Total Debt	0.07	0.07	0.17	0.3	0.48
Net Cash (Debt)	5.04	4.43	9.22	10.98	11.76
Net Cash Growth	13.75%	-51.96%	-15.97%	-6.63%	-43.72%
Net Cash Per Share	0.46	0.80	3.27	5.41	5.75
Filing Date Shares Outstanding	14.22	8.33	4.94	2.48	1.99
Total Common Shares Outstanding	14.22	8.33	4.94	2.48	1.99
Working Capital	2.7	4.39	9.67	10.98	11.49
Book Value Per Share	0.22	0.57	2.00	4.50	5.87
Tangible Book Value	3.1	4.74	9.88	11.16	11.7
Tangible Book Value Per Share	0.22	0.57	2.00	4.50	5.87
Machinery	0.09	0.1	0.12	-	-
Construction In Progress	0.34	0.33	0.06	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.